Turkmenistan - Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases

Since 2014, Turkmenistan Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases rose 25.4% year on year. At 649 Cases in 2019, the country was ranked number 58 comparing other countries in Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases. Turkmenistan is overtaken by Moldova, which was number 57 with 655 Cases and is followed by Nepal at 635 Cases. India ranked the highest with 66,255 Cases in 2019, a growth of 13.6% versus 2018. India, Russia and Russia respectively ranked number 2, 3 and 4 in this ranking. Republic of the Congo recorded the best 5 years average growth at +171.1% per year, while Croatia was the worst growing country at -100% per year.

Loading...

Date Units (Cases)
2019 649.00
2018 549.00
2017 343.00
2016 560.00
2015 268.00
Download all data from 2006 to 2019

How does Turkmenistan rank in Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases?

# 359 Countries Units (Cases) Last YoY 5‑years CAGR
1 #1
India
66,255 2019 +13.6 % +20.8 % View data
3 #3
Russia
29,181 2019 +5.0 % +13.4 % View data
55 #55
Uganda
726 2019 +7.2 % +23.3 % View data
58 #58
Turkmenistan
649 2019 +18.2 % +25.4 % View data
59 #59
Nepal
635 2019 -5.1 % +9.4 % View data
Compare all 359 countries

Go Top